Clinical Trials · NCT03798912
A First-in-Human Study of the RaniPill, an Oral Drug Delivery Platform
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- RANI Therapeutics
- Enrollment
- 62
- Start date
- Jul 2019
- Locations
- 1 site, Australia
- Primary endpoint
- Incidence and kind of adverse events possibly related to the RaniPill capsule